Hikari Power LTD Amgen Inc Transaction History

Hikari Power LTD

$1.2 Billion
Q3 2024

A detailed history of Hikari Power LTD transactions in Amgen Inc stock. As of the latest transaction made, Hikari Power LTD holds 30,990 shares of AMGN stock, worth $8.16 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

30,990

Previous 30,990 -0.0%

Holding current value

$8.16 Million

Previous $9.68 Million 3.12%

% of portfolio

0.83%

Previous 0.87%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $1.14 Million - $1.42 Million	-5,220 Reduced 14.42%	30,990 $8.33 Million
Q2 2022 Jul 06, 2022	BUY	$230.71 - $256.74 $76,134 - $84,724	330 Added 0.92%	36,210 $8.81 Million
Q1 2022 Apr 13, 2022	BUY	$219.27 - $242.57 $166,645 - $184,353	760 Added 2.16%	35,880 $8.68 Million
Q4 2021 Jan 12, 2022	BUY	$198.88 - $227.6 $338,096 - $386,920	1,700 Added 5.09%	35,120 $7.9 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $169,816 - $198,960	800 Added 2.45%	33,420 $7.11 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $203,744 - $250,022	-1,030 Reduced 3.06%	32,620 $7.69 Million
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $80,016 - $93,796	-480 Reduced 1.41%	33,650 $6.2 Million
Q3 2018 Oct 31, 2018	SELL	$185.29 - $208.89 $2.59 Million - $2.92 Million	-14,000 Reduced 29.09%	34,130 $7.08 Million
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $1.88 Million - $2.12 Million	-11,340 Reduced 19.07%	48,130 $8.88 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $254,145 - $297,000	1,500 Added 2.59%	59,470 $10.1 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $2.55 Million - $2.92 Million	15,270 Added 35.76%	57,970 $10.8 Million
Q2 2017 Aug 09, 2017	BUY	N/A	42,700	42,700 $7.35 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hikari Power LTD, based on Form 13F filings with the SEC.

News

Stay updated on Hikari Power LTD with notifications on news.

Account